Zerotuss Oral Suspension Sugar Free Mango contains Levocloperastine at a concentration of 20 mg per 5 ml and is indicated for the symptomatic relief of dry cough associated with various respiratory conditions. Levocloperastine is a non-opioid antitussive agent that acts centrally by suppressing the cough reflex without causing sedation or respiratory depression. This sugar-free formulation is particularly suitable for patients with diabetes or those requiring a reduced sugar intake. The mango-flavored suspension enhances palatability, improving patient compliance, especially in pediatric and geriatric populations. Zerotuss Oral Suspension is administered orally, with dosage adjusted according to age and severity of symptoms, under medical supervision. It is important to adhere to the prescribed dosage to avoid potential adverse effects such as gastrointestinal disturbances or hypersensitivity reactions. The medication should be used with caution in patients with a history of hypersensitivity to Levocloperastine or any excipients present in the formulation. Concomitant use with other central nervous system depressants should be monitored to prevent additive effects. Zerotuss Oral Suspension is intended for short-term use and patients are advised to seek medical consultation if symptoms persist beyond one week or worsen, to rule out underlying conditions requiring alternative treatment.